Albemarle Pref A ADR: 15min chart sees MACD Death Cross, Bearish Marubozu
ByAinvest
Monday, Oct 20, 2025 1:57 pm ET1min read
A--
Concurrent Investment Advisors LLC bought a new stake in Agilent Technologies during the second quarter, according to the same MarketBeat alert. The firm bought 2,260 shares of the medical research company's stock, valued at approximately $267,000.
Other hedge funds have also made changes to their positions in the company. Stone House Investment Management LLC purchased a new position in shares of Agilent Technologies in the 1st quarter valued at $30,000. Ransom Advisory Ltd purchased a new position in shares of Agilent Technologies in the 1st quarter valued at $32,000. Central Pacific Bank Trust Division purchased a new position in shares of Agilent Technologies in the 2nd quarter valued at $33,000. Zions Bancorporation National Association UT purchased a new position in shares of Agilent Technologies in the 1st quarter valued at $38,000. Finally, Costello Asset Management INC purchased a new position in shares of Agilent Technologies in the 1st quarter valued at $47,000, as noted in the MarketBeat alert.
Analysts have responded positively to Agilent Technologies' earnings report. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Agilent Technologies. Rothschild Redb raised shares of Agilent Technologies to a "strong-buy" rating. Wall Street Zen raised shares of Agilent Technologies from a "hold" rating to a "buy" rating. Barclays lifted their price target on shares of Agilent Technologies from $125.00 to $150.00 and gave the stock an "equal weight" rating. UBS Group raised shares of Agilent Technologies from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $130.00 to $170.00 — details reported in the MarketBeat alert.
Agilent Technologies, Inc. has a market capitalization of $40.26 billion, a P/E ratio of 33.34, a PEG ratio of 4.63, and a beta of 1.26. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71, and a current ratio of 2.25, according to the MarketBeat alert.
According to the 15-minute chart of Albemarle Pref A ADR, a MACD Death Cross has occurred, accompanied by a Bearish Marubozu at 10/20/2025 13:45. This indicates that the stock price has the potential to continue declining, as sellers are currently dominating the market, and bearish momentum is likely to persist.
Agilent Technologies Inc. (NYSE:A) reported earnings per share (EPS) of $1.37 for the last quarter, meeting analysts' expectations, while revenue increased by 10.1% year-over-year to $1.74 billion, according to a MarketBeat alert https://www.marketbeat.com/instant-alerts/filing-concurrent-investment-advisors-llc-takes-position-in-agilent-technologies-inc-a-2025-10-20/. The company also announced a quarterly dividend of $0.248 per share, with an annualized yield of 0.7%, reflecting a payout ratio of 23.24%.Concurrent Investment Advisors LLC bought a new stake in Agilent Technologies during the second quarter, according to the same MarketBeat alert. The firm bought 2,260 shares of the medical research company's stock, valued at approximately $267,000.
Other hedge funds have also made changes to their positions in the company. Stone House Investment Management LLC purchased a new position in shares of Agilent Technologies in the 1st quarter valued at $30,000. Ransom Advisory Ltd purchased a new position in shares of Agilent Technologies in the 1st quarter valued at $32,000. Central Pacific Bank Trust Division purchased a new position in shares of Agilent Technologies in the 2nd quarter valued at $33,000. Zions Bancorporation National Association UT purchased a new position in shares of Agilent Technologies in the 1st quarter valued at $38,000. Finally, Costello Asset Management INC purchased a new position in shares of Agilent Technologies in the 1st quarter valued at $47,000, as noted in the MarketBeat alert.
Analysts have responded positively to Agilent Technologies' earnings report. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Agilent Technologies. Rothschild Redb raised shares of Agilent Technologies to a "strong-buy" rating. Wall Street Zen raised shares of Agilent Technologies from a "hold" rating to a "buy" rating. Barclays lifted their price target on shares of Agilent Technologies from $125.00 to $150.00 and gave the stock an "equal weight" rating. UBS Group raised shares of Agilent Technologies from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $130.00 to $170.00 — details reported in the MarketBeat alert.
Agilent Technologies, Inc. has a market capitalization of $40.26 billion, a P/E ratio of 33.34, a PEG ratio of 4.63, and a beta of 1.26. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71, and a current ratio of 2.25, according to the MarketBeat alert.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet